The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration (Review)

35Citations
Citations of this article
45Readers
Mendeley users who have this article in their library.

Abstract

Spinal cord injury (SCI) is a traumatic lesion that can result in the loss of motor or sensory neurons. Stem cell (SC)-based therapies have been demonstrated to promote neuronal regeneration following SCI, by releasing a range of trophic factors that support endogenous repair or by differentiating into neurons, or glial cells in order to replace the damaged cells. However, numerous limitations remain for therapies based on SC transplantion alone, including a low rate of survival/engraftment. Nevertheless, scaffolds are 3-dimentional substrates that have revealed to support cell survival, proliferation and differentiation in vivo, by mimicking a more favorable endogenous microenvironment. A multidisciplinary approach, which combines engineered scaffolds with SCs has been proposed as a promising strategy for encouraging spinal cord regeneration. The present review has focused on the regenerative potential of mesenchymal SCs isolated from different sources and combined with various scaffold types, in preclinical and clinical SCI studies.

Cite

CITATION STYLE

APA

Libro, R., Bramanti, P., & Mazzon, E. (2017, October 1). The combined strategy of mesenchymal stem cells and tissue-engineered scaffolds for spinal cord injury regeneration (Review). Experimental and Therapeutic Medicine. Spandidos Publications. https://doi.org/10.3892/etm.2017.4939

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free